Medication Adherence of Patients with Selected Rheumatic Conditions: A Systematic Review of the Literature

Seminars in Arthritis and Rheumatism

Volumn 38, Issue 5, 2009, Pages 396-402

  Harrold, Leslie R ^a   Andrade, Susan E ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

adherence; arthritis; patient compliance; prescriptions drugs; rheumatoid arthritis

Indexed keywords

ALLOPURINOL; ANALGESIC AGENT; ANTIMALARIAL AGENT; COLCHICINE; DICLOFENAC; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; GLUCOCORTICOID; HYDROXYCHLOROQUINE; INFLIXIMAB; METHOTREXATE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; PREDNISOLONE; PREDNISONE; SALAZOSULFAPYRIDINE; SALICYLIC ACID DERIVATIVE; STEROID;

ANKYLOSING SPONDYLITIS; ARTHRITIS; ARTHROPATHY; ARTICLE; DEVICE; GOUT; HUMAN; INFLAMMATORY ARTHRITIS; JUVENILE RHEUMATOID ARTHRITIS; LABORATORY TEST; MEDICAL ASSESSMENT; MEDLINE; PATIENT COMPLIANCE; PHARMACY; PHYSICIAN; PILL; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; RHEUMATIC DISEASE; RHEUMATIC POLYMYALGIA; RHEUMATOID ARTHRITIS; SELF REPORT; SYSTEMATIC REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTIRHEUMATIC AGENTS; HUMANS; PATIENT COMPLIANCE; RHEUMATIC DISEASES;

EID: 63149094701     PISSN: 00490172     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2008.01.011     Document Type: Article

References (44)

1. Rogers P.G.B.W. Prescription medication compliance: a review of the baseline of knowledge. A report of the national council on patient information and patient education. J Pharmacoepidemiol Drug Saf 2 (1995) 3-36
2. Sackett D.L.H.R. Compliance with therapeutic regimens (1976), Johns Hopkins University Press, Baltimore
3. Gerth W.C. Compliance and persistence with newer antihypertensive agents. Curr Hypertens Rep 4 6 (2002) 424-433
4. Buchbinder R., Hall S., Sambrook P.N., Champion G.D., Harkness A., Lewis D., et al. Methotrexate therapy in rheumatoid arthritis: a life table review of 587 patients treated in community practice. J Rheumatol 20 4 (1993) 639-644
5. Osterberg L., and Blaschke T. Adherence to medication. [see comment]. N Engl J Med 353 5 (2005) 487-497
6. Belcon M.C., Haynes R.B., and Tugwell P. A critical review of compliance studies in rheumatoid arthritis. Arthritis Rheum 27 11 (1984) 1227-1233
7. Riedel A.A., Nelson M., Joseph-Ridge N., Wallace K., MacDonald P., and Becker M. Compliance with allopurinol therapy among managed care enrollees with gout: a retrospective analysis of administrative claims. J Rheumatol 31 8 (2004) 1575-1581
8. Dominick K.L., Golightly Y.M., and Bosworth H.B. Racial differences in analgesic/anti-inflammatory medication adherence among patients with osteoarthritis. Ethn Dis 15 1 (2005) 116-122
9. Bradley L.A. Adherence with treatment regimens among adult rheumatoid arthritis patients: current status and future directions. Arthritis Care Res 2 3 (1989) S33-S39
10. Brus H., van de Laar M., Taal E., Rasker J., and Wiegman O. Compliance in rheumatoid arthritis and the role of formal patient education. Semin Arthritis Rheum 26 4 (1997) 702-710
11. DiMatteo M.R. Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care 42 3 (2004) 200-209
12. Dunbar J., Dunning E.J., and Dwyer K. Compliance measurement with arthritis regimen. Arthritis Care Res 2 3 (1989) S8-1
13. Feinberg J. The effect of patient-practitioner interaction on compliance: a review of the literature and application in rheumatoid arthritis. Patient Educ Couns 11 3 (1988) 171-187
14. Rapoff M.A. Compliance with treatment regimens for pediatric rheumatic diseases. Arthritis Care Res 2 3 (1989) S40-S47
15. Rapoff M.A. Management of adherence and chronic rheumatic disease in children and adolescents. Best Pract Res Clin Rheumatol 20 2 (2006) 301-314
16. Tucker L.B. Caring for the adolescent with systemic lupus erythematosus. Adolesc Med 9 1 (1998) 59-67 vi
17. Wolfe F. The epidemiology of drug treatment failure in rheumatoid arthritis. Baillieres Clin Rheumatol 9 4 (1995) 619-632
18. Capell H.A. Compliance revisited. Br J Rheumatol 27 5 (1988) 337-338
19. Chambers S.A., Rahman A., and Isenberg D.A. Treatment adherence and clinical outcome in systemic lupus erythematosus. Rheumatology 46 6 (2007) 895-898
20. Liang M.H. Compliance and quality of life: confessions of a difficult patient. Arthritis Care Res 2 3 (1989) S71-S74
21. Rooney R.J., and Buchanan W.W. In rheumatoid arthritis is compliance in physicians more of a problem than compliance in patients?. Clin Rheumatol 9 3 (1990) 315-318
22. Treharne G.J., Lyons A.C., Hale E.D., Douglas K.M., and Kitas G.D. 'Compliance' is futile but is 'concordance' between rheumatology patients and health professionals attainable?. Rheumatology (Oxford) 45 1 (2006) 1-5
23. Weisman M.H., Bradley L.A., and Hovell M.F. Arthritis treatment, adherence, and behavioral medicine. Arthritis Care Res 2 3 (1989) S84-S86
24. Feldman D.E., de Civita M., Dobkin P.L., Malleson P., Meshefedjian G., and Duffy C.M. Perceived adherence to prescribed treatment in juvenile idiopathic arthritis over a one-year period. Arthritis Rheum 57 2 (2007) 226-233
25. de Klerk E., van der Heijde D., Landewe R., van der Tempel H., Urquhart J., and van der Linden S. Patient compliance in rheumatoid arthritis, polymyalgia rheumatica, and gout. J Rheumatol 30 1 (2003) 44-54
26. Adler M., Chambers S., Edwards C., Neild G., and Isenberg D. An assessment of renal failure in an SLE cohort with special reference to ethnicity, over a 25-year period. Rheumatology 45 9 (2006) 1144-1147
27. Mosley-Williams A., Lumley M.A., Gillis M., Leisen J., and Guice D. Barriers to treatment adherence among African American and white women with systemic lupus erythematosus. Arthritis Rheum 47 6 (2002) 630-638
28. Rojas-Serrano J., and Cardiel M.H. Lupus patients in an emergency unit. Causes of consultation, hospitalization and outcome. A cohort study Lupus 9 8 (2000) 601-606
29. Wang C., Fortin P.R., Li Y., Panaritis T., Gans M., and Esdaile J.M. Discontinuation of antimalarial drugs in systemic lupus erythematosus. J Rheumatol 26 4 (1999) 808-815
30. Sarawate C.A., Brewer K.K., Yang W., Patel P.A., Schumacher H.R., Saag K.G., et al. Gout medication treatment patterns and adherence to standards of care from a managed care perspective. Mayo Clin Proc 81 7 (2006) 925-934
31. Berry D., Bradlow A., and Bersellini E. Perceptions of the risks and benefits of medicines in patients with rheumatoid arthritis and other painful musculoskeletal conditions. Rheumatology (Oxford) 43 7 (2004) 901-905
32. Rapoff M.A., Belmont J.M., Lindsley C.B., and Olson N.Y. Electronically monitored adherence to medications by newly diagnosed patients with juvenile rheumatoid arthritis. Arthritis Rheum 53 6 (2005) 905-910
33. Taal E., Rasker J.J., Seydel E.R., and Wiegman O. Health status, adherence with health recommendations, self-efficacy and social support in patients with rheumatoid arthritis. Patient Educ Couns 20 2-3 (1993) 63-76
34. Owen S.G., Friesen W.T., Roberts M.S., and Flux W. Determinants of compliance in rheumatoid arthritic patients assessed in their home environment. Br J Rheumatol 24 4 (1985) 313-320
35. Park D.C., Hertzog C., Leventhal H., Morrell R.W., Leventhal E., Birchmore D., et al. Medication adherence in rheumatoid arthritis patients: older is wiser. J Am Geriatr Soc 47 2 (1999) 172-183
36. Tuncay R., Eksioglu E., Cakir B., Gurcay E., and Cakci A. Factors affecting drug treatment compliance in patients with rheumatoid arthritis. Rheumatol Int 27 8 (2007) 743-746
37. Beck N.C., Parker J.C., Frank R.G., Geden E.A., Kay D.R., Gamache M., et al. Patients with rheumatoid arthritis at high risk for noncompliance with salicylate treatment regimens. J Rheumatol 15 7 (1988) 1081-1084
38. Viller F., Guillemin F., Briancon S., Moum T., Suurmeijer T., and van den Heuvel W. Compliance to drug treatment of patients with rheumatoid arthritis: a 3 year longitudinal study. J Rheumatol 26 10 (1999) 2114-2122
39. Harley C.R., Frytak J.R., and Tandon N. Treatment compliance and dosage administration among rheumatoid arthritis patients receiving infliximab, etanercept, or methotrexate. Am J Manag Care 9 6 Suppl (2003) S136-S143
40. Doyle D.V., Perrett D., Foster O.J., Ensor M., and Scott D.L. The long-term use of D-penicillamine for treating rheumatoid arthritis: is continuous therapy necessary?. Br J Rheumatol 32 7 (1993) 614-617
41. Pullar T., Peaker S., Martin M.F., Bird H.A., and Feely M.P. The use of a pharmacological indicator to investigate compliance in patients with a poor response to antirheumatic therapy. Br J Rheumatol 27 5 (1988) 381-384
42. Wendling D., Materne G.E., Michel F., Lohse A., Lehuede G., Toussirot E., et al. Infliximab continuation rates in patients with rheumatoid arthritis in everyday practice. Joint Bone Spine 72 4 (2005) 309-312
43. Koneru S., Shishov M., Ware A., Farhey Y., Mongey A.B., Graham T.B., et al. Effectively measuring adherence to medications for systemic lupus erythematosus in a clinical setting. Arthritis Rheum 57 6 (2007) 1000-1006
44. Agras W.S. Understanding compliance with the medical regimen: the scope of the problem and a theoretical perspective. Arthritis Care Res 2 3 (1989) S2-S7